A Sher1, S L James, R Correa-Oliveira
1Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Vaccine development for schistosomiasis shows promise with identified parasite antigens conferring partial immunity in lab hosts. However, human vaccination requires overcoming challenges in inducing sufficient resistance against schistosome infections.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: